Efficacy and tolerability of Liraglutide in combination with other antidiabetic drugs in type 2 diabetes

Efficacy and tolerability of Liraglutide in combination with other antidiabetic drugs in type 2 diabetes

Authors

  • L. Zenari

Keywords:

Type 2 diabetes, GLP-1 receptor agonists, liraglutide

Abstract

We present a collection case report performed in 29 inadequately controlled diabetic and obese outpatients. The aim of this study was to verify metabolic effects of liraglutide in combination with other antidiabetic drugs. Across this study, liraglutide effectively and rapidly improves glycemic control (both fasting glycemia and HbA1c), body weight and systolic blood pressure, thus promoting the achievement of therapeutic targets proposed by the American Diabetes Association and European Association for the study of Diabetes and reducing cardiovascular risk profile of diabetic patients.

Downloads

Published

01-02-2012

Issue

Vol. 82 No. 3 (2011)

Section

CASE REPORTS

License

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. 
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

How to Cite

1.
Zenari L. Efficacy and tolerability of Liraglutide in combination with other antidiabetic drugs in type 2 diabetes. Acta Biomed [Internet]. 2012 Feb. 1 [cited 2024 Jul. 27];82(3):251-3. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/1736